Allogeneic hematopoietic stem-cell transplantation for myelofibrosis

Myelofibrosis is one of the Philadelphia chromosome (Ph)-negative myeloproliferative neoplasms with heterogeneous clinical course. Though many treatment options, including Janus kinase (JAK) inhibitors, have provided clinical benefits and improved survival, allogeneic hematopoietic stem-cell transpl...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Lining, Yang, Fan, Feng, Sizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019406/
https://www.ncbi.nlm.nih.gov/pubmed/32110286
http://dx.doi.org/10.1177/2040620720906002

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7019406/
https://www.ncbi.nlm.nih.gov/pubmed/32110286
http://dx.doi.org/10.1177/2040620720906002

Ejemplares similares